1. Signaling Pathways
  2. Immunology/Inflammation
  3. C-type Lectin-like Receptors (CTLRs)

C-type Lectin-like Receptors (CTLRs) (C-型凝集素样受体)

C-type Lectin-like Receptors (CTLRs)

C-型凝集素样受体 (CTLRs) 是一类含有类似 C 型凝集素结构域,但不一定依赖钙离子识别配体的蛋白质受体。根据其细胞内信号传导基序可分为激活受体和抑制受体。CTLRs 能够识别病原体相关分子模式 (PAMPs) 和损伤相关分子模式 (DAMPs),在先天性免疫和适应性免疫中发挥重要作用。结合配体后,CTLRs 作为抗原摄取受体,将抗原内化呈递给 T 细胞,并激活 NF-κB、IFN 和炎性小体等多种信号通路,调节免疫细胞功能。CTLRs 表达或功能的异常与肿瘤、感染性疾病和自身免疫性疾病等密切相关[1][2]

C-type Lectin-like Receptors (CTLRs) are a class of protein receptors that contain a C-type lectin-like domain but do not necessarily rely on calcium ions to recognize ligands. They are usually classified as activating or inhibitory receptors, based on their intracellular signaling motifs. CTLRs are capable of recognizing pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs), and play important roles in innate and adaptive immunity. After binding to ligands, CLRs act as antigen-uptake receptors, internalize antigens and present them to T cells, and activate multiple signaling pathways such as NF-κB, IFN, and inflammasomes to regulate the functions of immune cells. Abnormal expression or function of CLRs is closely related to cancer, infectious diseases, autoimmune diseases, and others[1][2].

C-type Lectin-like Receptors (CTLRs) 相关产品 (27):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-155312
    NKG2D-IN-2 Inhibitor
    NKG2D-IN-2 (compound 47) 是一种自然杀伤细胞群 2D 受体 (NKG2D) 抑制剂,在 NKG2D/MICA 和 ULBP6 TR-FRET 测定中,IC50 分别为 0.1 µM 和 0.2 µM。
    NKG2D-IN-2
  • HY-P990258
    Anti-Mouse CLEC9A/CD370 Antibody (7H11) Inhibitor
    Anti-Mouse CLEC9A/CD370 Antibody (7H11) 是一种源自大鼠的 IgG1 κ 型抗体抑制剂,靶向小鼠 CLEC9A/CD370。Anti-Mouse CLEC9A/CD370 Antibody (7H11) 与小鼠 CLEC9A (C 型凝集素结构域家族成员 9A) 发生反应并阻断 CLEC9A。Anti-Mouse CLEC9A/CD370 Antibody (7H11) 可用于癌症和免疫学的研究,如 B16.F10-OVA 肿瘤。
    Anti-Mouse CLEC9A/CD370 Antibody (7H11)
  • HY-P990829
    Anti-NKG2D/CD314 Antibody (1D11) Inhibitor
    Anti-NKG2D/CD314 Antibody (1D11) 是一种小鼠 IgG1 κ 嵌合抗体,靶向人 NKG2D/CD314。Anti-NKG2D/CD314 Antibody (1D11) 可阻断 NKG2D 与其配体的结合。Anti-NKG2D/CD314 Antibody (1D11) 可用于感染相关研究,如人类免疫缺陷病毒 (HIV)。
    Anti-NKG2D/CD314 Antibody (1D11)
  • HY-P991610
    S-095029 Inhibitor
    S-095029 是一种靶向 NKG2A 的人源化 IgG1 单克隆抗体抑制剂。S-095029 显著减弱 Fc 效应功能,并抑制其与配体 HLA-E 的相互作用,且能增强其他 Fc 功能完整抗体介导的抗体依赖性细胞毒作用。S-095029 具有强效抗肿瘤活性,在与癌细胞共培养时,可增强 NK 细胞和 γδ T 细胞的杀伤活性和细胞因子 (IFNγ、TNF-α 和 CXCL9) 的分泌。
    S-095029
  • HY-P991309
    ZM-008 Inhibitor
    ZM-008 是一种靶向 OCIL/CLEC2D 的人类单克隆抗体 (mAb)。ZM-008 可用于 B 细胞淋巴瘤、神经胶质瘤和前列腺癌的研究。
    ZM-008
  • HY-N0434R
    Astragaloside III (Standard)

    黄芪皂苷III (Standard)

    Activator
    Astragaloside III (Standard) 是 Astragaloside III (HY-N0434) 的分析标准品。本产品用于研究及分析应用。Astragaloside III 是一种三萜皂苷类化合物。Astragaloside III 可从黄芪中提取。Astragaloside III 增加 NKG2D,诱导 TACE 磷酸化。Astragaloside III 诱导凋亡 (Apoptosis)。Astragaloside III 对登革热血清型 1 和血清型 3 具有抗病毒活性。Astragaloside III 对乳腺癌、结肠癌具有抗癌活性。
    Astragaloside III (Standard)
  • HY-P990284
    Anti-Mouse CD205 Antibody (NLDC-145)
    Anti-Mouse CD205 Antibody (NLDC-145) 是一种源自大鼠的 IgG2a κ 型抗体抑制剂,靶向小鼠 CD205。Anti-Mouse CD205 Antibody (NLDC-145) 与 CD205 发生反应,也被称为 DEC-205。Anti-Mouse CD205 Antibody (NLDC-145) 可用于癌症、炎症、免疫学和代谢性疾病的研究,如结肠炎、D2F2/E2 肿瘤和糖尿病。
    Anti-Mouse CD205 Antibody (NLDC-145)